Phase 2 Review for Zoetis’ proposed acquisition of Neogen Genomics
The ACCC has announced that Zoetis Holdings LLC’s proposed acquisition of Neogen Corporation’s global animal genomic testing business (Neogen Genomics) could substantially lessen competition and requires Phase 2 review.
View ACCC media release.